title: Diabetic nephropathy and extracellular matrix.
abstract: Diabetic nephropathy (DN) is a serious complication in diabetes. Major typical morphological changes are the result of changes in the extracellular matrix (ECM). Thus, basement membranes are thickened and the glomerular mesangial matrix and the tubulointerstitial space are expanded, due to increased amounts of ECM. One important ECM component, the proteoglycans (PGs), shows a more complex pattern of changes in DN. PGs in basement membranes are decreased but increased in the mesangium and the tubulointerstitial space. The amounts and structures of heparan sulfate chains are changed, and such changes affect levels of growth factors regulating cell proliferation and ECM synthesis, with cell attachment affecting endothelial cells and podocytes. Enzymes modulating heparan sulfate structures, such as heparanase and sulfatases, are implicated in DN. Other enzyme classes also modulate ECM proteins and PGs, such as matrix metalloproteinases (MMPs) and serine proteases, such as plasminogen activator, as well as their corresponding inhibitors. The levels of these enzymes and inhibitors are changed in plasma and in the kidneys in DN. Several growth factors, signaling pathways, and hyperglycemia per se affect ECM synthesis and turnover in DN. Whether ECM components can be used as markers for early kidney changes is an important research topic, whereas at present, the clinical use remains to be established.
authors.affiliation: Department of Nutrition, Institute for Basic Medical Sciences, University of Oslo, Oslo, Norway. s.o.kolset@medisin.uio.no
authors.forename: S O
authors.initials: SO
authors.lastname: Kolset
authors.forename: F P
authors.initials: FP
authors.lastname: Reinholt
authors.forename: T
authors.initials: T
authors.lastname: Jenssen
mesh_terms: D000818:Animals; D002809:Chondroitin Sulfates / Q000378:metabolism; D003871:Dermatan Sulfate / Q000378:metabolism; D003929:Diabetic Neuropathies / Q000378:metabolism* / Q000503:physiopathology / Q000628:therapy; D005109:Extracellular Matrix / Q000378:metabolism*; D019276:Glycocalyx / Q000473:pathology; D019812:Heparan Sulfate Proteoglycans / Q000378:metabolism; D006801:Humans; D007668:Kidney / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D020782:Matrix Metalloproteinases / Q000378:metabolism; D011509:Proteoglycans / Q000378:metabolism*; D015398:Signal Transduction
chemical_list: D019812:Heparan Sulfate Proteoglycans; D011509:Proteoglycans; D003871:Dermatan Sulfate; D002809:Chondroitin Sulfates; D020782:Matrix Metalloproteinases